Filing Details

 

 

 

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

 

 

This Amendment No. 2 (“Amendment No. 2”) amends and supplements the statements on Schedule 13D filed with the Securities and Exchange Commission (the “SEC”) on May 25, 2016 (the “Original Schedule 13D,” together with Amendment No. 1 filed with the SEC on October 7, 2016 and this Amendment No. 2, the “Schedule 13D”), relating to shares of common stock, $0.01 par value per share (the “Common Stock”), of Accuride Corporation (the “Issuer”), a corporation organized under the laws of Delaware.  Capitalized terms used herein and not otherwise defined in this Amendment No. 2 have the meanings set forth in the Original Schedule 13D.  This Amendment No. 2 amends and supplements Item 4 as set forth below.

Item 4. Purpose of Transaction.

 

On October 21, 2016, the Reporting Persons filed with the SEC a preliminary proxy statement in order to solicit proxies in opposition to matters relating to the proposed Acquisition of the Issuer by affiliates of Crestview Partners, L.L.C.  On the same date, the Reporting Persons issued, and filed with the SEC, an open letter to stockholders of the Issuer urging them not to execute proxies solicited by or on behalf of the Issuer in connection with the Acquisition until they have received the Reporting Persons’ proxy materials.